Delivery Order SPE2DR25D3101-SPE2DR26F5W63
- Not listed
- The Defense Logistics Agency awarded a $22,002.23 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. REPATHA (evolocumab) is a PCSK9 inhibitor used in cardiovascular disease...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,776.39 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of December 10, 2025. The contract utilized firm fixed pricing under a non-competitive delivery order, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a single delivery order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $44,057.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside contract represents a competitive award to the prime contractor, which is headquartered in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $20,056.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens. The contract, which was not set-aside and competitively awarded, is scheduled for completion by August 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $16,007.47 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $14,080.56 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, PA. This delivery order represents a...
- The Defense Logistics Agency awarded a $26,066.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of December 31, 2025. This non-set-aside contract was competitively awarded on December 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. REPATHA is a specialty pharmaceutical product used to treat high cholesterol, and this delivery...
- The Defense Logistics Agency awarded a $10,732.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pharmaceutical product. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $31,392.68 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injector pens on January 7, 2026, with completion scheduled for January 8, 2026. This competitively awarded, firm fixed-price contract requires fulfillment at the awardee's facility in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in patients with established heart disease or...
- The Defense Logistics Agency awarded a delivery order valued at $12,614.03 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injector pens, with an ultimate completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5W63Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,334.71 to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pens on January 7, 2026, with completion scheduled for January 8, 2026. This firm fixed-price, non-set-aside delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of parent company Cencora, Inc., one of the nation's largest pharmaceutical distributors and a critical supplier to federal medical procurement systems. REPATHA is a specialty pharmaceutical used to treat high cholesterol and cardiovascular disease, reflecting the Defense Health Agency's ongoing need for specialty medications to support military and veteran healthcare populations. The delivery order demonstrates AmerisourceBergen's established capability to fulfill federal medical supply requirements through competitive procurement on an open and full basis. The company's substantial prime vendor contract with DLA enables efficient task order placement for diverse pharmaceutical products and medical commodities required by military treatment facilities and related healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 1/6/26 |